Back
Compare AU
Compare VESG vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Vanguard Ethically Conscious International Shares Index ETF (VESG) and the Betashares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
VESG | DRUG | |
|---|---|---|
Popularity | Medium | Low |
Pearlers invested | 2,587 | 67 |
Median incremental investment | $990.50 | $740.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,116.12 | $1,935.72 |
Average age group | 26 - 35 | > 35 |
Key Summary
VESG | DRUG | |
|---|---|---|
Strategy | VESG seeks to track the performance of the FTSE Developed ex-Australia Choice Index (with dividends reinvested) before considering any additional fees, expenses, and taxes. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Apple Inc. (5.54 %) Microsoft Corp. (4.67 %) Amazon.com Inc. (2.10 %) | BRL - BRAZILIAN REAL (0 %) AUD - AUSTRALIA DOLLAR (0 %) CHF - SWISS FRANC (0 %) |
Top 3 industries | Information Technology (26.14 %) Health Care (16.64 %) Financials (15.14 %) | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) |
Top 3 countries | United States (73.33 %) Japan (6.63 %) Switzerland (2.90 %) | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) |
Management fee | 0.18 % | 0.57 % |
Key Summary
VESG | DRUG | |
|---|---|---|
Issuer | Vanguard | BetaShares |
Tracking index | FTSE Developed ex Australia Choice Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.18 % | 0.57 % |
Price | $110.60 | $8.60 |
Size | N/A | $168.713 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.60 % | 1.97 % |
Market | ASX | ASX |
First listed date | 13/09/2018 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
VESG | DRUG | |
|---|---|---|
Popularity | Medium | Low |
Pearlers invested | 2,587 | 67 |
Median incremental investment | $990.50 | $740.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,116.12 | $1,935.72 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
VESG | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
VESG | DRUG |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |